Streetbeat News

Analyst Ratings

DGX

Quest Diagnostics (NYSE:DGX) has received indifferent ratings from four analysts in the last quarter. The average price target is $145.0, which is slightly above the current price of $141.92. This represents a 3.12% decrease from the previous average price target of $149.67.

Portfolio Pulse from Benzinga Insights

June 29, 2023 | 1:00 pm

ESTA

Establishment Labs Hldgs (NASDAQ:ESTA) has received positive ratings from analysts in the last quarter, with 3 bullish and 1 somewhat bullish ratings. The company has an average price target of $95.75, a decrease of 1.79% from the previous average price target of $97.50.

Portfolio Pulse from Benzinga Insights

June 29, 2023 | 1:00 pm

TEAM

Atlassian (NASDAQ:TEAM) has received a mix of bullish and indifferent analyst ratings over the last quarter. The average price target for the stock is $182.45, which is higher than its current price of $166.89. However, this average has decreased by 8.72% from the previous average price target of $199.89.

Portfolio Pulse from Benzinga Insights

June 29, 2023 | 1:00 pm

Micron Technology Inc's shares are rising after reporting better-than-expected Q3 results and receiving several analyst upgrades. The company reported Q3 revenue of $3.75 billion, beating the consensus estimate of $3.65 billion, and a quarterly loss of $1.43 per share, better than the estimated loss of $1.58 per share. However, the company's recovery and forecast are impacted by the Cyberspace Administration of China's decision to ban Chinese companies from buying Micron products.

Portfolio Pulse from Adam Eckert

June 29, 2023 | 12:57 pm

CPB

FDP

KHC

UNFI

VITL

The article lists the top 5 oversold stocks in the consumer staples sector, which could present buying opportunities. The stocks mentioned are The Kraft Heinz Company (KHC), Campbell Soup Company (CPB), Vital Farms, Inc (VITL), Fresh Del Monte Produce Inc. (FDP), and United Natural Foods, Inc. (UNFI). All these stocks have an RSI value below 30, indicating they are oversold.

Portfolio Pulse from Lisa Levin

June 29, 2023 | 12:53 pm

FHTX

GDOT

GIS

INVH

LBTYK

PFE

REAL

ROIV

SDGR

SYM

Portfolio Pulse from Lisa Levin

June 29, 2023 | 12:53 pm

JOBY

KTRA

RNXT

RenovoRx (RNXT) announced positive interim Phase III data showing RenovoGem™ delays cancer progression by eight months in locally advanced pancreatic cancer. Joby (JOBY) received a $100 million investment as it expands its partnership with SK Telecom. Kintara Therapeutics (KTRA) was awarded a $2.0 million National Institutes of Health SBIR grant to support the clinical development of REM-001.

Portfolio Pulse from Benzinga Newsdesk

June 29, 2023 | 12:41 pm

NKE

Nike Inc. (NYSE:NKE) is expected to release its Q4 2023 financial results on June 29, 2023. Options markets are implying a move of around +/-6.38% following the earnings release, which is 2% below its historical average. Traders are buying puts, indicating an expectation of Nike's shares trading lower by the end of the week. Analysts expect Nike to post quarterly earnings at 67 cents per share on revenue of $12.59 billion.

Portfolio Pulse from Lisa Levin

June 29, 2023 | 12:36 pm

WING

Guggenheim analyst Matthew Difrisco has initiated coverage on Wingstop (NASDAQ:WING) with a Neutral rating.

Portfolio Pulse from richadhand@benzinga.com

June 29, 2023 | 12:35 pm

FREY

Morgan Stanley has upgraded FREYR Battery's stock from Equal-Weight to Overweight and set a price target of $13. This has led to an increase in the trading of FREYR Battery shares.

Portfolio Pulse from Benzinga Newsdesk

June 29, 2023 | 12:34 pm